Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
30/04 | 1,640 USD
+3,80% |
+3,80% |
|
Cabaletta Bio Inc |
30/04 | 1,320 USD
+3,12% |
+3,12% |
|
Calithera Biosciences Inc |
16/04 | 0,005 USD
+733,33% |
+733,33% |
|
Can-Fite Biopharma Ltd |
30/04 | 1,090 USD
0,00% |
0,00% |
|
Capricor Therapeutics Inc |
30/04 | 12,700 USD
+1,11% |
+1,11% |
|
Cara Therapeutics Inc |
15/04 | 5,320 USD
-4,14% |
-4,14% |
Carbios |
30/04 | 8,190 EUR
-0,73% |
-0,73% |
|
Carisma Therapeutics, Inc. |
30/04 | 0,199 USD
-2,26% |
-2,26% |
|
CASI Pharmaceuticals Inc |
30/04 | 1,940 USD
-2,76% |
-2,76% |
|
Cel-Sci Corp. |
30/04 | 0,290 USD
0,00% |
0,00% |
|
Celldex Therapeutics Inc. |
30/04 | 20,830 USD
-0,48% |
-0,48% |
|
Cellectar Biosciences Inc |
30/04 | 0,252 USD
-13,54% |
-13,54% |
|
Cellectis |
30/04 | 1,645 USD
+3,46% |
+3,46% |
|
Cellectis |
30/04 | 1,396 EUR
+0,43% |
+0,43% |
Celyad Oncology |
30/04 | 0,462 EUR
-1,70% |
-1,70% |
|
Champions Oncology Inc |
30/04 | 7,150 USD
-4,92% |
-4,92% |
|
Chimerix Inc |
17/04 | 8,540 USD
-0,12% |
-0,12% |
|
Cidara Therapeutics Inc |
30/04 | 20,885 USD
-1,11% |
-1,11% |
|
Co-Diagnostics Inc |
30/04 | 0,351 USD
-2,01% |
-2,01% |
|
Cogent Biosciences Inc |
30/04 | 5,210 USD
+3,78% |
+3,78% |
|
Coherus Biosciences Inc |
30/04 | 1,030 USD
+3,04% |
+3,04% |
|
CollPlant Biotechnologies Ltd |
30/04 | 2,120 USD
-4,29% |
-4,29% |
|
Compass Pathways Plc |
30/04 | 3,980 USD
+5,57% |
+5,57% |
|
Compugen Ltd. |
30/04 | 1,600 USD
+14,29% |
+14,29% |
|
Corbus Pharmaceuticals Holdings Inc |
30/04 | 7,470 USD
+3,75% |
+3,75% |
|
CRISPR Therapeutics AG |
30/04 | 38,670 USD
+3,40% |
+3,40% |
|
Cue Biopharma Inc |
30/04 | 0,755 USD
-1,24% |
-1,24% |
|
Curis Inc |
30/04 | 2,110 USD
+16,57% |
+16,57% |
|
Cyclacel Pharmaceuticals Inc |
30/04 | 0,258 USD
-15,01% |
-15,01% |
|
Cyclacel Pharmaceuticals Inc |
30/04 | 4,500 USD
-2,39% |
-2,39% |
|
Cytokinetics Inc |
30/04 | 42,840 USD
+3,75% |
+3,75% |
|
CytomX Therapeutics Inc |
30/04 | 0,744 USD
+14,23% |
+14,23% |